Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Collaborative Groups / Lung and Upper Aerodigestive Cancers Research Group / Identification of an autoantibody panel of markers (c-Myc, Cyclin A, Cyclin B1, Cyclin D1, CDK2 and Suvivin) for early detection of lung cancer.

Identification of an autoantibody panel of markers (c-Myc, Cyclin A, Cyclin B1, Cyclin D1, CDK2 and Suvivin) for early detection of lung cancer.

EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.